PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

2020 vision of vaccines for malaria, TB and HIV/AIDS

In a Nature Perspective Seattle BioMed's Aderem shares insight into rational vaccine development using new approaches

2011-05-26
(Press-News.org) SEATTLE, WA, May 25, 2011 – Collectively, malaria, TB & HIV/AIDS cause more than five million deaths per year – nearly the entire population of the state of Washington – and represent one of the world's major public health challenges as we move into the second decade of the 21st century. In the May 26, 2011, edition of the premier scientific journal Nature, Seattle BioMed Director Alan Aderem, Ph.D., along with Rino Rappuoli, Ph.D., Global Head of Vaccines Research for Novartis Vaccines & Diagnostics, discuss recent advances in vaccine development, along with new tools including systems biology and structure-based antigen design that could lead to a deeper understanding of mechanisms of protection. This, in turn, will illuminate the path to rational vaccine development to lift the burden of the world's most devastating infectious diseases.

According to Aderem, a systems biology pioneer who recently joined Seattle BioMed to incorporate that approach with the Institute's infectious disease research, new conceptional and technological advances indicate that it will be possible to develop vaccines for the "big three" infectious diseases within the next 10 years. "Success will be largely dependent on our ability to use novel approaches such as systems biology to analyze data sets generated during proof-of-concept trials," he explained. "This will lead to new insights such as the identification of correlates of protection or signatures of immunogenicity and the acceleration of large-scale clinical trials." Aderem added that innovative, new clinical and regulatory approaches will also accelerate the pathway to much-needed vaccines.

The article discusses the strengths and criticisms of the systems biology approach, with the key strength of the approach lying in its ability to capture and integrate massive amounts of biological data to visualize emergent properties that are not demonstrated by their individual parts and cannot be predicted from the parts alone. "The power of systems biology comes from its capacity to predict the behavior of an entire biological system," Aderem said. "From there, we can optimize vaccine candidates and predict whether a drug or vaccine candidate can work before it moves into large scale, very expensive clinical trials."

Systems biology can also be used to speed the often lengthy clinical trial experience. Aderem and Rappuoli estimate that in trials of new vaccines for malaria, TB and HIV/AIDS, only one hypothesis has been tested every eight years in the past three decades. "We cannot afford this approach if we want to have an impact on disease in a reasonable timeframe," Aderem said. "We can accelerate clinical development by performing more efficacy trials and by improving their design using systems biology approaches to test several hypotheses in parallel and having an adaptive design to expand the outcomes that prove most promising."

Aderem and Rappuoli also debunk one of the key criticisms of systems biology – that it is overly reliant on computation. "Much of this comes from a misunderstanding on the role of computers in systems biology," Aderem explained. "Computers are not expected to come up with biological insights from the outset, but are meant to facilitate an integration of discovery science with hypothesis-driven science to yield a holistic description of a biological system."

While progress has been made over the past few years in the development of novel vaccines against the three most challenging infectious diseases in the world, Aderem and Rappuoli conclude that innovative design of clinical trials, testing several vaccines in parallel and getting early information using systems biology approaches will accelerate vaccine development and increase understanding of the human immune system.

INFORMATION:

ABOUT SEATTLE BIOMEDICAL RESEARCH INSTITUTE:

Seattle BioMed is the largest independent, non-profit organization in the U.S. focused solely on infectious disease research. Our research is the foundation for new drugs, vaccines and diagnostics that benefit those who need our help most: the 14 million who will otherwise die each year from infectious diseases, including malaria, HIV/AIDS and tuberculosis. Founded in 1976, Seattle BioMed has more than 360 staff members. By partnering with key collaborators around the globe, we strive to make discoveries that will save lives sooner. For more information, visit www.seattlebiomed.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Can we get there from here? Translating stem cell research into therapies

2011-05-26
A new article published by Cell Press in the May 26 issue of the journal Neuron provides comprehensive insight into the current status of neural stem cell research and the sometimes labyrinthine pathways leading to stem cell-based therapies. The perspective on translating neural stem cell research into clinical therapeutics is part of a special issue of Neuron devoted to neural stem cells and neurogenesis and is published in collaboration with the May issue of Cell Stem Cell, which also has a selection of reviews on this topic. Neurological disease and injury are a major ...

Endangered gourmet sea snail could be doomed by increasing ocean acidity

2011-05-26
Increasing levels of ocean acidity could spell doom for British Columbia's already beleaguered northern abalone, according to the first study to provide direct experimental evidence that changing sea water chemistry is negatively affecting an endangered species. The northern abalone--prized as a gourmet delicacy--has a range that extents along the North American west coast from Baja California to Alaska. Even though British Columbia's northern abalone commercial fisheries where closed in 1990 to protect dwindling populations, the species has continued to struggle, largely ...

Japan earthquake appears to increase quake risk elsewhere in the country

2011-05-26
Japan's recent magnitude 9.0 earthquake, which triggered a devastating tsunami, relieved stress along part of the quake fault but also has contributed to the build up of stress in other areas, putting some of the country at risk for up to years of sizeable aftershocks and perhaps new main shocks, scientists say. After studying data from Japan's extensive seismic network, researchers from the Woods Hole Oceanographic Institution (WHOI), Kyoto University and the U.S. Geological Survey (USGS) have identified several areas at risk from the quake, Japan's largest ever, which ...

Syracuse University scientists discover new hitch to link nerve cell motors to their cargo

2011-05-26
With every bodily movement—from the blink of an eye to running a marathon—nerve cells transmit signals to muscle cells. To do that, nerve cells rely on tiny molecular motors to transport chemical messengers (neurotransmitters) that excite muscles cells into action. It's a complex process, which scientists are still trying to understand. A new study by Syracuse University researchers has uncovered an important piece of the puzzle. The study, published in the April 22 issue of the Journal of Biological Chemistry (JBC), describes the discovery of a protein that is involved ...

Rethinking extinction

Rethinking extinction
2011-05-26
For more than 40 years, the International Union for Conservation of Nature (IUCN) has published the Red List of Threatened Species describing the conservation status of various species of animals. They are now also including plants in their lists and the picture they present is dramatic. According to recent estimates, around 20 per cent of flowering plants are currently at risk of extinction – though the exact number is unknown since such a small proportion of plant species has even been measured. Now, however, research conducted in South Africa and the U.K. by an international ...

Study shows elderly drivers support competency tests

2011-05-26
AURORA, Colo. (May 25, 2011) – Researchers studying driving habits and accident rates among the elderly found a majority surveyed supported mandatory retesting of drivers based on age while saying they would hand over the keys if a doctor or loved one said they were no longer fit to drive. "We are now exploring the idea of an advance directive for driving where someone would be designated to take away your keys at some point," said Emmy Betz, MD, MPH, at the University of Colorado School of Medicine who led the study and presented it in May before the American Society ...

Study details path to sustainable aviation biofuels industry in Northwest

2011-05-26
SEATTLE–The Pacific Northwest has the diverse feedstocks, fuel-delivery infrastructure and political will needed to create a viable biofuels industry capable of reducing greenhouse gases and meeting the future fuel demands of the aviation industry. Creating an aviation biofuels industry, however, will depend upon securing early government policy support to prioritize the aviation industry in U.S. biofuel development. That's the conclusion announced today in a 10-month study by Sustainable Aviation Fuels Northwest (SAFN), the nation's first regional stakeholder effort to ...

Most labor unions unlikely to follow decertification path of NFL players

Most labor unions unlikely to follow decertification path of NFL players
2011-05-26
CHAMPAIGN, Ill. — With legislation to diminish private- and public-sector collective bargaining rights already in the books in Wisconsin and Ohio, should more labor unions steal a page from the playbook of the NFL Players Association and decertify? Although there are parallels between the pros and regular Joes (and Janes), union decertification is not a viable strategy for ordinary workers to use when bargaining for better wages and working conditions, says a University of Illinois law and labor expert. Whether it's a teacher in Wisconsin or a construction worker in Indiana, ...

Autism changes molecular structure of the brain, UCLA study finds

2011-05-26
For decades, autism researchers have faced a baffling riddle: how to unravel a disorder that leaves no known physical trace as it develops in the brain. Now a UCLA study is the first to reveal how the disorder makes its mark at the molecular level, resulting in an autistic brain that differs dramatically in structure from a healthy one. Published May 25 in the advance online edition of Nature, the findings provide new insight into how genes and proteins go awry in autism to alter the mind. The discovery also identifies a new line of attack for researchers, who ...

Caltech-led team debunks theory on end of 'Snowball Earth' ice age

Caltech-led team debunks theory on end of Snowball Earth ice age
2011-05-26
PASADENA, Calif.—There's a theory about how the Marinoan ice age—also known as the "Snowball Earth" ice age because of its extreme low temperatures—came to an abrupt end some 600 million years ago. It has to do with large amounts of methane, a strong greenhouse gas, bubbling up through ocean sediments and from beneath the permafrost and heating the atmosphere. The main physical evidence behind this theory has been samples of cap dolostone from south China, which were known to have a lot less of the carbon-13 isotope than is normally found in these types of carbonate rocks. ...

LAST 30 PRESS RELEASES:

What can polymers teach us about curing Alzheimer's disease?

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Skin cancer cluster found in 15 Pennsylvania counties with or near farmland

For platforms using gig workers, bonuses can be a double-edged sword

Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon

New study reveals key role of inflammasome in male-biased periodontitis

MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer

Donors enable record pool of TPDA Awards to Neuroscience 2025

Society for Neuroscience announces Gold Sponsors of Neuroscience 2025

The world’s oldest RNA extracted from woolly mammoth

Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show

Reading a quantum clock costs more energy than running it, study finds

Early MMR vaccine adoption during the 2025 Texas measles outbreak

Traces of bacteria inside brain tumors may affect tumor behavior

Hypertension affects the brain much earlier than expected

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio

Drift logs destroying intertidal ecosystems

New test could speed detection of three serious regional fungal infections

New research on AI as a diagnostic tool to be featured at AMP 2025

New test could allow for more accurate Lyme disease diagnosis

New genetic tool reveals chromosome changes linked to pregnancy loss

New research in blood cancer diagnostics to be featured at AMP 2025

Analysis reveals that imaging is overused in diagnosing and managing the facial paralysis disorder Bell’s palsy

Research progress on leptin in metabolic dysfunction-associated fatty liver disease

Fondazione Telethon announces CHMP positive opinion for Waskyra™, a gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS)

Vaccine Innovation Center, Korea University College of Medicine hosts an invited training program for Ethiopian Health Ministry officials

FAU study finds small group counseling helps children thrive at school

Research team uncovers overlooked layer of DNA that may shape disease risk

Study by Incheon National University could transform skin cancer detection with near-perfect accuracy

[Press-News.org] 2020 vision of vaccines for malaria, TB and HIV/AIDS
In a Nature Perspective Seattle BioMed's Aderem shares insight into rational vaccine development using new approaches